1.Effects of TDP Radiation on Bone Marrow Erythroblastic Cells in Mice
Journal of Third Military Medical University 1986;0(S1):-
The effects of TDP radiation and infrared rays on the erythroblastic cells of the bone marrow were studied and compared in mice irradiated with gamma rays from a 60Co sourse. The rate of 58Fe-citrate incorporation and other parameters were determined.It was found that the 59Fe incorporation rate, the number of uncleated cells, the mitotic index, the labelling index, and the labelled mitotic index in the bone marrow of the mice of TDP irradiated group were significantly higher than those of the control(P0.05). Ont he basis of the results, it might be concluded that TDP radiation can promote the synthesis of corpuscular hemoglobin, which in turn accelerates erythropoiesis.
2.EFFECTS OF 4-AMINOPYRIDINE ON CALCIUM CURRENTS AND SODIUM CURRENTS IN GUINEA PIG VENTRICULAR MYOCYTES
Liying FU ; Yang LI ; Guojin XIA ; Weixing YAO ; Mingxing JIANG
Acta Pharmaceutica Sinica 2001;36(4):250-253
AIM To investigate the effect of 4-aminopyridine (4-AP) on ion channels of myocytes. METHODS L-type calcium channel and sodium channel currents were recorded in guinea pig single ventricular myocyte using whole-cell patch-clamp techniques. RESULTS 4-AP, 0.1, 0.5 and 1.0 mmol*L-1 were shown to inhibit L-type calcium channel currents (ICa,L) and sodium channel currents (INa) concentration-dependently. The percentage of inhibition were (11.6±1.7)%, (37.5±8.3)% and (54.5±6.9)% (P<0.01) respectively for ICa,L, and (22.1±14.3)% (P<0.05), (39.4±8.8)% and (62.3±6.8)% (P<0.01) respectively for INa. 4-AP 0.5 mmol*L-1 shifted the I-V curves of ICa,L and INa upwardly. CONCLUSION 4-AP blocked L-type calcium channel and sodium channels in guinea-pig ventricular myocytes concentration-dependently.
3.Expression of muc-1 gene in non-small cell lung cancer and its clinical significance
Guanghu LI ; Wei LIU ; Tong FU ; Guojin LIU
Journal of Jilin University(Medicine Edition) 2006;0(06):-
Objective To explore the relationship between expression of muc-1 gene in non-small cell lung cancer (NSCLC) tissues and lymph node metastasis and its clinical significance.Methods The expression of muc-1 gene in 36 specimens of NSCLC tissues and 10 normal lung tissues were determined by RT-PCR.Results muc-1 gene was positively expressed in 19 of 36 specimens of NSCLC tissues,the positive expression rate was 52.7%.The expression of muc-1 mRNA in NSCLC tissues was related to metastasis of lymph node(?2 =6.733,P0.05).The positive expression rate of muc-1 gene was higher in NSCLC tissues with lymph node metastasis(N0 10%,N1 58.82%,N2 88.9%).Conclusion The lymph node metastasis rate in NSCLC patients with muc-1 gene positive expression is higher,the detection of muc-1 gene expression can guide the prognosis and therapy of NSCLC patients after operation.
4.The long-term efficacy and safety of rituximab combined with cyclophosphamide in treatment of seven patients with refractory and recurrent autoimmune hemolytic anemia
Hong LIU ; Limin XING ; Huaquan WANG ; Yuhong WU ; Wen QU ; Yong LIANG ; Guojin WANG ; Jia SONG ; Xiaoming WANG ; Jing GUAN ; Lijuan LI ; Rong FU ; Zonghong SHAO
Chinese Journal of Internal Medicine 2012;51(6):456-459
Objective To assess the efficacy and safety of monoclonal antibody rituximab combined with cyclophosphamide (CTX) in the treatment of refractory and recurrent autoimmune hemolytic anemia.Methods Seven cases with refractory and recurrent autoimmune hemolytic anemia ( including 1 case of Evans syndrome) were recruited during January,2007 to December,2010.Treatment regimens were as follows:rituximab:375 mg/m2,1 time/week,2-6 courses; CTX:1 g,1/10 d,2-7 courses; combined with intravenous immunoglobulin (IVIG) 5 g,1 time/week,given 1 day after rituximab administration.The efficacy and safety of this regimen were assessed during follow-up.Results All the patients showed good responses (7/7).Six patients achieved complete remission (6/7) and one achieved partial remission ( 1/7 ).Average follow-up time for the patients was 27 months.All patients remained in remission during the 12-month follow-up visits.Two patients showed elevated indirect bilirubin and increased reticulocyte counts within 24 months.One patient achieved complete remission after additional rituximab therapy,and another patient remained partial remission after cyclosporine therapy.At the time of 36-month follow-up visit,the patient relapsed and was retreated with 3 courses of rituximab combined with CTX and eventually achieved partial remission.All patients tolerated the treatment well with few mild side effects.Conclusions Rituximab combined with CTX is effective and relatively safe in patients with refractory and recurrent autoimmune hemolytic anemia.Additional treatment to relapse patients about 12-24 months after drug withdrawal continues to be effective.
5.The expression and its clinical significance of granulocyte colony-stimulating factor receptor in acute myelocytic leukemia
Lin FU ; Zonghong SHAO ; Rong FU ; Yong LIANG ; Wen ZHAI ; Guojin WANG ; Huaquan WANG ; Limin XING ; Yuhong WU ; Hong LIU ; Jia SONG ; Jing GUAN ; Jun WANG ; Lijuan LI ; Yue REN ; Hui LIU ; Xiaoming WANG ; Erbao RUAN
Chinese Journal of Practical Internal Medicine 2001;0(06):-
Objective To investigate the expression of granulocyte colony-stimulating factor receptor(G-CSFR,CD114)in acute myelocytic leukemia(AML)bone marrow CD34+cells and evaluate G-CSF's secutiy of applying to the patients of AML after chemotherapy.Methods From March 2008 to January 2009,62 AML patients[33 deno-vo or relapsed AML patients,29 AML patients in complete remission(CR)]and 16 normal controls in the General Hospital,Tianjin Medical University were detected for the expression of G-CSFR in CD34+cells by Fluorescence-activated cell sorer(FCM)and Semi-quantitative reverse transcription-polymerase chain reaction(RT-PCR).Results The ratio of CD114+CD34+/CD34+ in the deno-vo or relapsed group,CR group and the control group were(11.69?2.91)%,(31.84?8.62)%,(32.87?8.44)% respectively(P0.05),G-CSFR mRNA expression in BMNNCs of the deno-vo or relapsed group,CR group and the control group were(30.52?6.21)%,(85.13?21.25)%,(91.57?18.64)% respectively(P0.05).13 AML patients were followed up.The ratio of CD114+CD34+/CD34+ before treatment and in CR were(12.58?2.00)% and (30.13?7.09)% respectively.The ratio before treatment was lower than that in CR(P
6.Quantity and apoptosis-related protein levels of CD4+, CD25+, and CD127low regulatory T cells in peripheral blood of multiple myeloma patients
Shuchong MEI ; Limin XING ; Rong FU ; Huaquan WANG ; Lijuan LI ; Wen QU ; Guojin WANG ; Hong LIU ; Xiaoming WANG ; Jia SONG ; Yuhong WU ; Jing GUAN ; Erbao RUAN ; Hui LIU ; Chunyan LIU ; Tian ZHANG ; Shaoxue DING ; Zonghong SHAO
Chinese Journal of Clinical Oncology 2014;(13):840-844
To investigate the role of CD4+, CD25+, and CD127low regulatory T cells (Tregs) in multiple myeloma (MM). Methods:Levels of CD4+T cells and Tregs, as well as expression of CTLA-4 and apoptosis-related proteins, such as CD95, bcl-2, and Caspase3 of Tregs in peripheral blood of 30 patients with newly diagnosed cases, 27 patients under of complete remission (CR) from multiple myeloma patients, and 25 healthy adults were analyzed by flow cytometry. Results:The percentage of CD4+T cells in the untreated group was significantly lower than that of the control group (P<0.05). The percentage of Tregs in CD4+T cells in the untreated group was significantly higher than that of the CR group and control group (P<0.05), which in ISSⅢpatients of the untreated group was significantly higher than that in I/II(P<0.05). No significant difference of CD95 expression in Tregs was observed among the three groups. The expression of CTLA-4 in Tregs from the untreated group was significantly higher than that of the CR group (P<0.05) and control group (P<0.01), and so was in CR group than this in controls (P<0.05). The expression of bcl-2 in Tregs in the untreated group was significantly higher than that of the CR group (P<0.05) and control group (P<0.01), and so was in CR group than this in controls(P<0.05). The expression of Caspase3 in Tregs from the untreated group and CR group were all significantly lower than that of the control group (P<0.05). The percentage of Tregs in CD4+T cells in the untreated group was positively correlated with the proportion of bone marrow plasma cells (P<0.05). The percentage of Tregs in CD4+T cells from 15 MM patients who received bortezamib and dexamethasone (VD) chemotherapy was negatively correlated to the ratio of plasma cell reduction after the first VD chemotherapy (r=0.735, P<0.01). Conclusion:The level of Tregs in the peripheral blood of MM patients was positively correlated with tumor burden and progression of disease, but was negatively correlated with curative effect. The increased level of Tregs was associated with their strengthened anti-apoptosis function.
7.The expression and its clinical significances of interleukin-3 receptor alpha on Bone Marrow cells of the patients with acute myelocytic leukemia.
Haoran HU ; Yong LIANG ; Rong FU ; Guojin WANG ; Huaquan WANG ; Limin XING ; Wen QU ; Jing GUAN ; Yuhong WU ; Hong LIU ; Jia SONG ; Yue REN ; Hui LIU ; Xiaoming WANG ; Jun WANG ; Lijuan LI ; Erbao RUAN ; Zonghong SHAO
Chinese Journal of Practical Internal Medicine 2001;0(05):-
Objective To investigate the expression of interleukin-3 receptor alpha(CD123)on bone marrow cells in acute myelocytic leukemia(AML)and its clinical significances.Methods By means of Fluorescence-activated cell sorer(FACS)and semi-quantity reverse transcripition polymerase chain reaction(RT-PCR),the expression of IL-3R?(CD123+)protein on CD34+CD38-cells and mRNA in BMMNCs of 62 AML patients of Tianjin Medical University General Hospital from March 2008 to January 2009 and 12 normal controls were detected respectively;Then the correlation between IL-3R? and the clinical stages of AML were analyzed.Results CD34+CD38-CD123+/CD34+CD38-and IL-3R? mRNA in BMMNC of 33 deno-vo or relapsed AML patients were higher than those of control group(P
8.Study of the effect of iron overload on the bone marrow hematopoietic function in immuo-related pancytopenia patients
Yili GU ; Zonghong SHAO ; Rong FU ; Yong LIANG ; Wen QU ; Huaquan WANG ; Guojin WANG ; Jia SONG ; Hong LIU ; Yuhong WU ; Limin XING ; Jing GUAN ; Jun WANG ; Lijuan LI ; Xiaoming WANG ; Erbao RUAN
Chinese Journal of Practical Internal Medicine 2001;0(06):-
Objective To study the effect of iron overload on the bone marrow hematopoietic function on immuo-related pancytopenia(IRP)patients by hematopoietic progenitor cell(HPC)culture of bone marrow(BM).Methods BM liquid 4~5 mL was taken from 46 IRP patients of General Hospital Tianjin Medical University from July 2009 to February 2010 to detect colony-forming-unit of erythrocyte,blast-forming-unit of erythrocyte and colony-forming-unit of granulocyte-monocyteby HPC culture of BM.And according to the serum ferritin(SF)level,these patients were classified into 2 groups to compare HPC proliferation,blood cell counts,BM proliferation,blood transfusion and treatment effects.Results The mean values of 3 different colonies of IRP patients with high SF level [(43.33?17.74),(1.50?2.2),(11.06?5.83)/105BMMNC] were significantly lower than those of the patients with normal SF level [(77.43?40.64),(9.57?7.99),(21.25?11.41)/105BMMNC](P
9.Clinical experience of integrated blood purification in treatment of patients with liver failure due to paraquat poisoning
Hongying BI ; Jianyu FU ; Yan TANG ; Yumei CHENG ; Yuanyi LIU ; Hongxia WANG ; Guojin QIAO ; Difen WANG
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2017;24(6):660-662
The lung is a major target organ in acute paraquat (PQ) poisoning, but early PQ-induced severe liver failure is also an important life-threatening situation that can't be neglected. At present, toxin elimination through blood purification is a routine effective therapy recommended at the initial stage of PQ poisoning. However, the mode, therapeutic course and efficacy of blood purification for treatment of liver failure induced by PQ intoxication are still further to be explored. Theoretically, PQ is a substance with small molecule soluble in water, so hemofiltration (HF) is more suitable to be applied for treatment of PQ poisoning, but since PQ itself elimination rate (170 mL/min) from the kidney is far greater than the extracorporeal elimination rate of HF, it is suggested that HF be used only in cases with kidney functional injury caused by PQ poisoning. After PQ intoxication, a great amount of inflammatory mediators are produced; under this circumstance, if continuous veno-venous hemo-filtration (CVVH) is applied, its convection and dispersion features can remove the inflammatory mediators and toxin. Using hemoperfusion (HP) combined with CVVH not only can reduce the concentration of PQ but also can decrease plasma cytokine levels and ameliorate the organ damages. Thus, in cases with hepatic and renal functional damage, the application of combination of HP and CVVH is more effective for the treatment. Bilirubin adsorption can not only reduce bilirubin, but also can decrease PQ concentration, and it is also a means to treat PQ poisoning. In this article, the experience of using CVVH combined with HP, plasma separation and bilirubin adsorption for treatment of 1 case with liver failure induced by PQ poisoning was reported.
10.An analysis of efficacy and related factors of itraconazole in the treatment of invasive fungal infection in hematological diseases
Chunyan LIU ; Rong FU ; Yuhong WU ; Erbao RUAN ; Wen QU ; Guojin WANG ; Yong UANG ; Xiaoming WANG ; Hong UU ; Jia SONG ; Jing GUAN ; Huaquan WANG ; Limin XING ; Lijuan LI ; Jun WANG ; Zonghong SHAO
Chinese Journal of Internal Medicine 2010;49(6):504-507
Objective To investigate the effects and related factors of itraconazole in the treatment of invasive fungal infection (IFI) in the patients with blood diseases ( BD). Methods A total of 156 BD patients with IFI treated with itraconazole in General Hospital, Tianjin Medical University from 2005 to 2008, were retrospectively analyzed. Results Of these patients, 92 were with underlying malignant BD, and 64 with non-malignant BD; 77 possible IFI, and others proven IFI. A total of 94 (63. 5% ) patients were responded to itraconazole successfully, while 54 (36. 5% ) failed. The underlying malignant BD, post-chemotherapy, neutrophil count less than 0. 5 x 109/L, positive fungus culture, and bacteria infection were related with the response to itraconazole significantly, while patient's age, application of other antibiotics,positive C test, IFI localization, haemoglobin level and platelet counts were not Five patients was changed other anti-IFI therapy because of side effects, including gastrointestinal ill (3 cases with nausea or vomiting) and tachycardia (2 cases). Conclusions Itraconazole was effective and safe in the treatment of IFI in the patients with BD. Underlying malignant BD, agranulocytosis, bacteria infection, and delayed anti-IFI therapy might reduce itraconazole therapeutic effects.